Biogen and Apple Collaborate to Launch Virtual Study on Cognitive Decline
Shots:
- Biogen and Apple collaborated to evaluate the role of Apple Watch and iPhone in monitoring cognitive performance and screening for the decline in cognitive health including mild cognitive impairment (MCI)
- The study will initiate in late 2021 and will enroll participants including young and aging adults with a range of cognitive performance
- The study focuses to identify digital biomarkers to aid monitor cognitive performance and health including potentially detecting mild cognitive impairment- an early indicator of certain forms of dementia such as AD
Ref: Biogen | Image: Biogen
Click here to read the full press release
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com